AVITA Medical, Inc. (RCEL) Form 8-K — Jun 3, 2026
AVITA Medical, Inc. (RCEL) held its 2026 Annual Meeting of Stockholders on June 3, 2026, where all seven named directors were re-elected to the Board. Stockholders also ratified the appointment of Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2026. Shareholders approved several equity-related proposals, including annual grants of restricted stock units and options to non-executive directors, as well as initial grants to Dr.
Key figures
- Shares Outstanding
- 30776689
- Shares Voted
- 15592447
- Director Fee Pool Max
- 900000
- Warrants Authorized
- 650000
Price after filing
1 day: +4.8%7 days: -1.0%30 days: +21.6%
Close on the filing date to close N calendar days later (from $4.16). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.